MatthewNathanHarrisMDFAAD

Dermatology • Hinsdale, IL

Clinical Dermatologist and Co-Founder/Executive Committee Member Illinois Dermatology Institute, LLC

Join to view full profile

Dr. Harris is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Harris' full profile

Already have an account?

Office
901 North Elm Street
Suite 250
Hinsdale, IL 60521
Phone+1 630-325-6880

Fax+1 630-325-5975
Is this information wrong?

Education & Training

New York Medical College (Metropolitan)Residency, Dermatology, 2000 - 2003
Ascension St Vincent Hospital IndianapolisInternship, Transitional Year, 1999 - 2000
Indiana University School of MedicineClass of 1999

Certifications & Licensure

IL State Medical License 2003 - 2026
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EMA EMR, Modernizing Medicine, Inc., 2013
Fellow (FASDS) American Society for Dermatologic Surgery
Fellow (FAAD) American Academy of Dermatology
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

Publications & Presentations

PubMed

3 citations
A novel immunization strategy using cytokine/chemokines induces new effective systemic immune responses, and frequent complete regressions of human metastatic melanoma.
Fred T. Valentine, Frederick M. Golomb, Matthew N. Harris, Daniel F. Roses> ;Oncoimmunology. 2018 Jan 1
45 citations
Changes in the Presence of Multiple Markers of Circulating Melanoma Cells Correlate with Clinical Outcome in Patients with Melanoma
Sandra R. Reynolds, Jeffrey H. Albrecht, Richard L. Shapiro, Daniel F. Roses, Matthew N. Harris, Andrew Conrad, Anne Zeleniuch-Jacquotte, Jean-Claude Bystryn> ;Clinical Cancer Research. 2003 Apr 1
38 citations
Vaccine-induced CD8+ T-cell responses to MAGE-3 correlate with clinical outcome in patients with melanoma.
Sandra R. Reynolds, Anne Zeleniuch-Jacquotte, Richard L. Shapiro, Daniel F. Roses, Matthew N. Harris, Dean Johnston, Jean-Claude Bystryn> ;Clinical Cancer Research. 2003 Feb 1
74 citations
Double-blind trial of a polyvalent, shed-antigen, melanoma vaccine.
Jean-Claude Bystryn, Anne Zeleniuch-Jacquotte, Ruth Oratz, Richard L. Shapiro, Matthew N. Harris, Daniel F. Roses> ;Clinical Cancer Research. 2001 Jul 1
3 citations
Decrease in circulating tumor cells as an early marker of therapy effectiveness.
Jean-Claude Bystryn, Jeffrey H. Albrecht, Sandra R. Reynolds, M. C. Rivas, Ruth Oratz, Richard L. Shapiro, Daniel F. Roses, Matthew N. Harris, Andrew Conrad> ;Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer. 2001 Jan 1
13 citations
Invasive carcinoma in clinically suspicious breast masses diagnosed as adenocarcinoma by fine-needle aspiration.
David C. Chhieng, Gerardo Fernandez, Joan Cangiarella, Jean Marc Cohen, Jerry Waisman, Matthew N. Harris, Daniel F. Roses, Richard L. Shapiro, W. Fraser Symmans> ;Cancer. 2000 Apr 25
127 citations
Complications of level I and II axillary dissection in the treatment of carcinoma of the breast.
Daniel F. Roses, Ari D. Brooks, Matthew N. Harris, Richard L. Shapiro, J S Mitnick> ;Annals of Surgery. 1999 Aug 1
5 citations
Irsogladine Maleate Inhibits Angiogenesis in Wild-Type and Plasminogen Activator-Deficient Mice
Christine J. Ren, Fusao Ueda, Daniel F. Roses, Matthew N. Harris, Paolo Mignatti, Daniel B. Rifkin, Richard L. Shapiro> ;The Journal of Surgical Research. 1998 Jul 1
23 citations
Poly(ADP-ribose) polymerase in human breast cancer: A case-control analysis
Jennifer J. Hu, George C. Roush, Neil Dubin, Marianne Berwick, Daniel F. Roses, Matthew N. Harris> ;Pharmacogenetics. 1997 Aug 1
32 citations
Urokinase-type plasminogen activator-deficient mice are predisposed to staphylococcal botryomycosis, pleuritis, and effacement of lymphoid follicles.
Richard L. Shapiro, J. G. Duquette, Irene Nunes, Daniel F. Roses, Matthew N. Harris, Wilson El, Daniel B. Rifkin> ;The American Journal of Pathology. 1997 Jan 1
98 citations
Induction of Primary Cutaneous Melanocytic Neoplasms in Urokinase-Type Plasminogen Activator (uPA)-deficient and Wild-Type Mice: Cellular Blue Nevi Invade but Do Not P...
Richard L. Shapiro, J. G. Duquette, Daniel F. Roses, Irene Nunes, Matthew N. Harris, Hideko Kamino, Wilson El, Daniel B. Rifkin> ;Cancer Research. 1996 Aug 1
33 citations
The management of pigmented lesions of the nail bed.
Paul M. Glat, Jason A. Spector, Daniel F. Roses, Richard A. Shapiro, Matthew N. Harris, Robert W. Beasley, John A.I. Grossman> ;Annals of Plastic Surgery. 1996 Aug 1
15 citations
Stereotactic fine-needle aspiration biopsy for the evaluation of nonpalpable breast lesions: Report of an experience based on 2,988 cases
J S Mitnick, M F Vazquez, Peter I. Pressman, Matthew N. Harris, Daniel F. Roses> ;Annals of Surgical Oncology. 1996 Mar 1
6 citations
Sinus histiocytosis mimicking metastatic melanoma in lymph nodes of a patient with a large joint prosthesis: case report and review of the literature.
Caleb K. Charny, Glenn R. Jacobowitz, Jonathan Melamed, Mona Tata, Matthew N. Harris> ;Journal of Surgical Oncology. 1995 Oct 1
9 citations
Management considerations for melanonychia striata and melanoma of the hand
Paul M. Glat, Richard L. Shapiro, Daniel F. Roses, Matthew N. Harris, John A.I. Grossman> ;Hand Clinics. 1995 May 1
11 citations
Stereotactic aspiration biopsy of nonpalpable nodules of the breast.
M F Vazquez, J S Mitnick, P. Pressman, Matthew N. Harris, Daniel F. Roses> ;Journal of the American College of Surgeons. 1994 Jan 1
1 citations
Stereotaxic aspiration biopsy of the breast.
J S Mitnick, M F Vazquez, Daniel F. Roses, Matthew N. Harris, J. Waisman> ;Radiology. 1993 Dec 1
4 citations
Fine needle aspiration biopsy in patients with augmentation prostheses and a palpable mass.
J S Mitnick, M F Vazquez, Kathy Plesser, Peter I. Pressman, Matthew N. Harris, Daniel F. Roses> ;Annals of Plastic Surgery. 1993 Sep 1
7 citations
Distinction between postsurgical changes and carcinoma by means of stereotaxic fine-needle aspiration biopsy after reduction mammaplasty.
J S Mitnick, M F Vazquez, Kathy Plesser, P. Pressman, Matthew N. Harris, Stephen R. Colen, Daniel F. Roses> ;Radiology. 1993 Aug 1
6 citations
Stereotactic localization for fine needle aspiration biopsy in patients with augmentation prostheses.
J S Mitnick, M F Vazquez, Daniel F. Roses, Matthew N. Harris, Stephen R. Colen, Helen S. Colen> ;Annals of Plastic Surgery. 1992 Jul 1
8 citations
Recurrent breast cancer: stereotaxic localization for fine-needle aspiration biopsy. Work in progress.
J S Mitnick, M F Vazquez, Daniel F. Roses, Matthew N. Harris, S Schechter> ;Radiology. 1992 Jan 1
7 citations
The risk of carcinoma in wire localization biopsies for mammographically detected clustered microcalcifications.
Daniel F. Roses, J. R. Mitnick, Matthew N. Harris, Kaplon R, Nolan S. Karp, M F Vazquez, Dubin N> ;Surgery. 1991 Nov 1
34 citations
Volume of malignant melanoma is superior to thickness as a prognostic indicator. Preliminary observation.
R. J. Friedman, D S Rigel, Alfred W. Kopf, Caron M. Grin, Edward Heilman, Robert S. Bart, Hideko Kamino, Matthew N. Harris, Daniel F. Roses, Allen Postel> ;Dermatologic Clinics. 1991 Oct 1
21 citations
Stereotaxic localization for fine-needle aspiration breast biopsy. Initial experience with 300 patients.
J S Mitnick, M F Vazquez, Daniel F. Roses, Matthew N. Harris, Rosamond Gianutsos, Jerry Waisman> ;Archives of Surgery. 1991 Sep 1
17 citations
Lack of effect of cyclophosphamide on the immunogenicity of a melanoma antigen vaccine.
Ruth Oratz, Margaret Dugan, Daniel F. Roses, Matthew N. Harris, James L. Speyer, Howard S. Hochster, Jolie Weissman, Mila Henn, Jean-Claude Bystryn> ;Cancer Research. 1991 Jul 15
Join now to see all